Jazz Pharmaceuticals
JAZZ
JAZZ
375 hedge funds and large institutions have $9.64B invested in Jazz Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 120 increasing their positions, 103 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 323 → 375 (+52)
3.23% more ownership
Funds ownership: 90.14% → 93.36% (+3.2%)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
375
Holding in Top 10
10
Calls
$117M
Puts
$58.7M
Top Buyers
| 1 | +$294M | |
| 2 | +$123M | |
| 3 | +$91.1M | |
| 4 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$87.3M |
| 5 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
+$78.3M |
Top Sellers
| 1 | -$391M | |
| 2 | -$83.8M | |
| 3 | -$80.7M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$55M |
| 5 |
Goldman Sachs
New York
|
-$44.7M |